InvestorsHub Logo
Post# of 316446
Next 10
Followers 364
Posts 113761
Boards Moderated 5
Alias Born 12/28/2000

Re: None

Monday, 04/01/2024 9:48:43 AM

Monday, April 01, 2024 9:48:43 AM

Post# of 316446
IRON down 56% Disc Medicine on Monday said a phase 2 study of its bitopertin drug candidate in patients with a rare, inherited metabolic disorder met its main goal but missed a key secondary target.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.